Vladislav A. Malkov

Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1

Vladimír Petrovič, Vladislav A. Malkov, Andrew N. Billin, Uptal D. Patel et autres

us (code pays fourni par la source)

Filgotinib treatment modulates frequency and gene expression of circulating immune cell subsets in ulcerative colitis

Emily Wendt, Yan Liang, Grace Park, Duncan Hindmarch et autres

us (code pays fourni par la source)

Plasma proteome signatures of ASK1 inhibition by selonsertib associate with efficacy in the MOSAIC randomized trial for diabetic kidney disease

Vladimír Petrovič, Andrew Whiteman, Matt Peach, Samuel Kim et autres

es, us (code pays fourni par la source)

Antidiabetic and lipid‐lowering medication use inversely linked with serum biomarkers of liver fibrosis

Jun Wang, Dora Ding, Xiaorong Shao, Lily Ma et autres

us (code pays fourni par la source)

Plasma Proteome Signatures of ASK1 Inhibition by Selonsertib Associate with Efficacy in the MOSAIC Randomized Trial for Diabetic Kidney Disease

Vladimír Petrovič, Andrew Whiteman, Matt Peach, Samuel Kim et autres

us (code pays fourni par la source)

Author response for "Antidiabetic and lipid‐lowering medication use inversely linked with serum biomarkers of liver fibrosis"

Jun Wang, Dora Ding, Xiaorong Shao, Lily Ma et autres

Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral therapy for hepatitis B virus can decrease kidney disease risk

Kaori Ito, Yuqing Zhang, Biao Li, Andrew King et autres

us (code pays fourni par la source)

Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study

Hiroshi Nakase, Silvio Danese, Walter Reinisch, Timothy E. Ritter et autres

jp, it, at, us, be, nl (code pays fourni par la source)

Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis

Douglas Thorburn, Diana Julie Leeming, William Barchuk, Ya Wang et autres

gb, dk, us (code pays fourni par la source)

Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study

Cynthia Levy, Stephen H. Caldwell, Parvez Mantry, Velimir A. Luketic et autres

us (code pays fourni par la source)

Correction: Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate

Yoshiya Tanaka, Peter C. Taylor, Emon Elboudwarej, Angie Hertz et autres

jp, gb, us (code pays fourni par la source)

Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial

Vinod Chandran, Vladislav A. Malkov, Kaori Ito, Yihua Liu et autres

ca, us (code pays fourni par la source)